Humalog kwikpen and Slurred speech - from FDA reports

Slurred speech is reported only by a few people who take Humalog Kwikpen. We study 299 people who have side effects while taking Humalog kwikpen from FDA. Among them, 1 have Slurred speech. Find out below who they are, when they have Slurred speech and more.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our original studies have been referenced on 400+ peer-reviewed medical publications, including: The Lancet, and Mayo Clinic Proceedings.

On Mar, 31, 2018

299 people reported to have side effects when taking Humalog kwikpen.
Among them, 1 person (0.33%) has Slurred speech

Number of reports submitted per year:

Could Humalog kwikpen cause Slurred speech?

Gender of people who have Slurred speech when taking Humalog kwikpen *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Slurred speech when taking Humalog kwikpen *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 100 %
  • 60+: 0.0 %

Top conditions involved for these people *:

  • Metastases To Central Nervous System (cancer spreads to central nervous system): 1 person, 100.00%

Top co-used drugs for these people *:

  • Sutent: 1 person, 100.00%
  • Simvastatin: 1 person, 100.00%
  • Lisinopril: 1 person, 100.00%

Top other side effects for these people *:

  • Vision Blurred: 1 person, 100.00%
  • Haemorrhage Intracranial (bleeding within the skull): 1 person, 100.00%
  • Gait Disturbance: 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

Do you take Humalog kwikpen and have Slurred speech?

Related studies

Humalog kwikpen

Humalog kwikpen has active ingredients of insulin lispro recombinant. It is often used in diabetes. (latest outcomes from Humalog kwikpen 364 users)

Slurred speech

Slurred speech (slow speech that can be difficult to understand) has been reported by people with multiple sclerosis, high blood pressure, depression, pain, rheumatoid arthritis (latest reports from 47,725 Slurred speech patients).

Drugs that are associated with Slurred speech
Slurred speech (2,805 drugs)
Could your condition cause Slurred speech
Slurred speech (2,634 conditions)
Expand the study to include all drugs with the same ingredients
Slurred speech and drugs with ingredients of insulin lispro recombinant. (316 reports)
Expand the study to include reports from both FDA and eHealthMe
Slurred speech and Humalog kwikpen from FDA and eHealthMe reports
Humalog kwikpen side effects
Browse all side effects of Humalog kwikpen
a b c d e f g h i j k l m n o p q r s t u v w x y z

Analysis tools (to study 684 million drug outcomes from FDA)

  • Check symptoms - identify the cause of a symptom: from a drug or from a condition?
  • Check drugs - find out common side effects or drug interactions of my drugs.
  • Compare drugs - compare the side effects and efficacy of multiple drugs side by side.

What would happen?

Predict new side effects and undetected conditions when you take Humalog kwikpen and have Slurred speech

You are not alone. Join our personalized support groups:

Can you answer these questions

More questions for: Humalog kwikpen, Slurred speech

You may be interested in these posts

More posts for: Humalog kwikpen, Slurred speech

Recent updates

General studies
Active Support Groups
Recent Predictions
Personalized studies

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.